GlassScriptPhysician profile
Zosima B Carino-Gateb
NPI 1508842741
$857.42
in general payments reported to CMS, 2019-2025
8 companies · $75.40 in 2025
The $75.40 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $164 · 2021: $108 · 2022: $81.37 · 2023: $131 · 2024: $141 · 2025: $75.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $293.00 | 2019-2025 | Bexsero |
| Sanofi Pasteur INC. | $144.84 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $130.22 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Pfizer INC. | $72.91 | 2021-2024 | |
| Cranial Technologies, INC | $69.57 | 2020-2024 | Doc Band |
| Phadia US INC. | $66.97 | 2019-2023 | Immunocap |
| Seqirus USA INC | $56.46 | 2021-2024 | Flucelvax |
| Ars Pharmaceuticals Operations, INC. | $23.45 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zosima Carino-Gateb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.